Rimegepant is a pharmaceutical raw material used as a calcitonin gene-related peptide (CGRP) receptor antagonist. It is employed in the manufacturing of orally dissolving formulations for migraine management.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Rimegepant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Rimegepant sulfate
pharmaceutical raw material
Ubrogepant
pharmaceutical raw material
Atogepant
pharmaceutical raw material
Warfarin sodium
pharmaceutical raw material
Ergonovine maleate
pharmaceutical raw material
Buclizine dihydrochloride
pharmaceutical raw material
Nirogacestat
pharmaceutical raw material
(5R,6R,9S)-Rimegepant
pharmaceutical raw material
The international HS code for Rimegepant (CAS 1289023-67-1) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate
KRNAOFGYEFKHPB-ANJVHQHFSA-N
C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6
Sourcing Rimegepant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.